` REDX (Redx Pharma PLC) vs FTSE All Share Index Comparison - Alpha Spread

R
REDX
vs
F
FTSE All Share Index

Over the past 12 months, REDX has underperformed FTSE All Share Index, delivering a return of 0% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
REDX vs FTSE All Share Index

Loading
REDX
FTSE All Share Index
Add Stock

Performance Gap
REDX vs FTSE All Share Index

Loading
REDX
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
REDX vs FTSE All Share Index

Loading
REDX
FTSE All Share Index
Add Stock

Competitors Performance
Redx Pharma PLC vs Peers

FTSE All Share Index
REDX
LLY
JNJ
ROG
NOVO B
Add Stock

Redx Pharma PLC
Glance View

Market Cap
50.2m GBX
Industry
Pharmaceuticals

Redx Pharma Plc engages in the discovery and development of proprietary, small molecule drugs to address areas of high, unmet medical need. The company is headquartered in Macclesfield, Cheshire and currently employs 71 full-time employees. The company went IPO on 2015-03-27. The Company’s product pipeline includes RXC004 and ROC007. Its lead product candidate RXC004, which is a potent, selective, oral small molecule inhibitor of the enzyme, Porcupine, a key activator of Wnt ligands in the Wnt signalling pathway. RXC004 is in Phase I study in combination with nivolumab (OPDIVO- Bristol Myers Squibb, an anti-PD-1 antibody). The RXC007 is a selective small molecule inhibitor that targets Rho Associated Coiled-Coil Containing Protein Kinase 2 (ROCK2) which sits at a nodal point in a cell signaling pathway. RXC007 is used for the treatment of fibrotic diseases.

REDX Intrinsic Value
Not Available
R
Back to Top